sciensano.be
Published on sciensano.be (https://sciensano.be)

Home > Biblio > Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study

Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study

Effectiveness and safety of vaccines, medicines and health products - Quality of medical laboratories  

Peer reviewed scientific article

English

SCIENSANO

Authors

Queeny Robalo [1]; Laurane De Mot [2]; Mathil Vandromme [3]; Nina Van Goethem [4]; Andrea Gabrio [5]; Pui Yan Jenny Chung [6]; Marjan Meurisse [7]; Lucy Catteau [8]; Carel Thijs [9]; Koen Blot [10]

Keywords

    Article written during project(s) : 
    LINK-VACC Linking of registers for COVID-19 vaccine surveillance [11]

    Associated health topics:

    Post-authorisation surveillance of COVID-19 vaccines [12]

    Source URL:https://sciensano.be/en/biblio/association-between-covid-19-primary-vaccination-and-severe-disease-caused-sars-cov-2-delta-variant

    Links
    [1] https://sciensano.be/en/biblio?f%5Bauthor%5D=182838&f%5Bsearch%5D=Queeny%20Robalo [2] https://sciensano.be/en/people/laurane-de-mot/biblio [3] https://sciensano.be/en/people/mathil-vandromme/biblio [4] https://sciensano.be/en/people/nina-van-goethem/biblio [5] https://sciensano.be/en/biblio?f%5Bauthor%5D=182839&f%5Bsearch%5D=Andrea%20Gabrio [6] https://sciensano.be/en/biblio?f%5Bauthor%5D=182427&f%5Bsearch%5D=Pui%20Yan%20Jenny%20Chung [7] https://sciensano.be/en/biblio?f%5Bauthor%5D=177100&f%5Bsearch%5D=Marjan%20Meurisse [8] https://sciensano.be/en/people/lucy-catteau/biblio [9] https://sciensano.be/en/biblio?f%5Bauthor%5D=182840&f%5Bsearch%5D=Carel%20Thijs [10] https://sciensano.be/en/people/koen-blot/biblio [11] https://sciensano.be/en/projects/linking-registers-covid-19-vaccine-surveillance [12] https://sciensano.be/en/health-topics/post-authorisation-surveillance-covid-19-vaccines